The Pharmaceutical Journal
Vol 279 No 7475 p463
27 October 2007

This article
Reprint   Photocopy

  Acrobat Reader

News summary

MDS that can accommodate liquids unveiled

A monitored dosage system (MDS) that can accommodate liquid medicines has been launched by Protomed, the company behind Nomad MDS.

The company claims that the system, known as Biodose, is the first in the world that can accomodate liquid medicines as well as tablets and capsules.

It also incorporates a patented antimicrobial technology — Biocote — which, Protomed says, protects against the transfer of infections such as meticillin-resistant Staphylococcus aureus.

Protomed plans to make Biodose available in the first quarter of 2008.